According to the research report titled ‘Global Vitamin D Therapy Market Size study, by Route of administration (Oral and Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases and Others) and Regional Forecasts 2021-2027’, available with Market Study Report, global vitamin D therapy market was valued at USD 2.11 billion in 2020 and is reckoned to record a compound annual growth rate of 11.3% over 2021-2027 to accumulate USD 4.47 billion by the end of analysis timeframe.
 

Rising prevalence of conditions like rickets and osteoporosis fueling the demand for Vitamin D-rich foods, huge elderly population base, and rising expenditure in healthcare sector are catalyzing the growth of global vitamin D therapy market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3891249/
 

According to The Centers for Disease Control and Prevention, osteoporosis at either lumbar spine or femur neck or both as well as low bone mass within adults of 50 years & above was 12.6% and 43.1% respectively in 2017-2018. Osteoporosis was more prevalent among women (19.6%) than in men (4.45), likewise low bone mass was recorded more among women (51.5%) compared with men (33.5%).
 

For the unversed, vitamin D is a collection of fat-soluble secosteroids which helps the body in absorbing calcium from the diet, making them essential for strong bones. Lack of vitamin D in the body can lead to osteoporosis or rickets and other bone diseases. Sedentary lifestyle leading to vitamin deficiency among the masses is another precursor for various health conditions, impelling the demand for vitamin D therapy.
 

Despite the positive outlook, regulations to curb vitamin D toxicity in some regions is likely to hamper the worldwide Vitamin D therapy market development over the projected timeframe.
 

From regional frame of reference, North America currently holds a major market share, owing to increasing per capita income, and rising awareness about Vitamin D benefits. Meanwhile, Asia Pacific industry is anticipated to grow significantly over the assessment period, accreditable to soaring geriatric populace, and increasing cases of osteoporosis.
 

Speaking of competitive landscape, Cadila Healthcare Limited, Alkem Laboratories Limited, Sun Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited, Sanofi S.A., Abbott Laboratories, Merck & Co., Inc., GlaxoSmithKline plc, Pfizer, Inc., and Novartis International AG are the major players influencing global vitamin D therapy market trends.